Development of Therapeutic Products for Antibiotic Resistant Bacteria
Development of Therapeutic Products for Antibiotic Resistant Bacteria
抗生素耐药细菌治疗产品的开发
批准号：
10830899
负责人：
TERRY BOWLIN
金额：
$83.09万
依托单位：
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-07-01 至 2024-04-17
关键词：
Advanced DevelopmentBacterial Antibiotic ResistanceCategoriesChemistryClinicalDevelopmentEmerging Communicable DiseasesNational Institute of Allergy and Infectious DiseasePathway interactionsPseudomonas aeruginosaefficacy evaluationmanufacturepre-clinicalpriority pathogenproduct developmentresearch and developmentsafety assessmenttherapeutic candidatetherapeutic development
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To support the advanced development of a promising candidate therapeutic for NIAID Category A, B, and C Priority Pathogens or emerging infectious diseases. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF PAN-FILOVIRUS THERAPEUTICS
-
批准号：10899099
-
项目类别：
-
资助金额：$206.94万
-
财政年份：2022
-
负责人：TERRY BOWLIN
-
依托单位：
Development of Therapeutic Products for Antibiotic Resistant Bacteria
-
批准号：10269556
-
项目类别：
-
资助金额：$90.49万
-
财政年份：2020
-
负责人：TERRY BOWLIN
-
依托单位：
Development of Therapeutic Products for Antibiotic Resistant Bacteria
-
批准号：10585903
-
项目类别：
-
资助金额：$29.96万
-
财政年份：2020
-
负责人：TERRY BOWLIN
-
依托单位：
海外基金
